Inhibitory Role of Notch1 in Calcific Aortic Valve Disease

Aortic valve calcification is the most common form of valvular heart disease, but the mechanisms of calcific aortic valve disease (CAVD) are unknown. NOTCH1 mutations are associated with aortic valve malformations and adult-onset calcification in families with inherited disease. The Notch signaling pathway is critical for multiple cell differentiation processes, but its role in the development of CAVD is not well understood. The aim of this study was to investigate the molecular changes that occur with inhibition of Notch signaling in the aortic valve. Notch signaling pathway members are expressed in adult aortic valve cusps, and examination of diseased human aortic valves revealed decreased expression of NOTCH1 in areas of calcium deposition. To identify downstream mediators of Notch1, we examined gene expression changes that occur with chemical inhibition of Notch signaling in rat aortic valve interstitial cells (AVICs). We found significant downregulation of Sox9 along with several cartilage-specific genes that were direct targets of the transcription factor, Sox9. Loss of Sox9 expression has been published to be associated with aortic valve calcification. Utilizing an in vitro porcine aortic valve calcification model system, inhibition of Notch activity resulted in accelerated calcification while stimulation of Notch signaling attenuated the calcific process. Finally, the addition of Sox9 was able to prevent the calcification of porcine AVICs that occurs with Notch inhibition. In conclusion, loss of Notch signaling contributes to aortic valve calcification via a Sox9-dependent mechanism.

[1]  Javier Bermejo,et al.  Diet-Induced Aortic Valve Disease in Mice Haploinsufficient for the Notch Pathway Effector RBPJK/CSL , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[2]  K. McBride,et al.  Heredity of bicuspid aortic valve: is family screening indicated? , 2011, Heart.

[3]  R. Hinton,et al.  Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. , 2011, Journal of molecular and cellular cardiology.

[4]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[5]  M. Zenke,et al.  Activated Notch1 Target Genes during Embryonic Cell Differentiation Depend on the Cellular Context and Include Lineage Determinants and Inhibitors , 2010, PloS one.

[6]  J. Lincoln,et al.  Reduced Sox9 Function Promotes Heart Valve Calcification Phenotypes In Vivo , 2010, Circulation Research.

[7]  D. Srivastava,et al.  Notch1 represses osteogenic pathways in aortic valve cells. , 2009, Journal of molecular and cellular cardiology.

[8]  K. Yutzey,et al.  Notch pathway regulation of chondrocyte differentiation and proliferation during appendicular and axial skeleton development , 2009, Proceedings of the National Academy of Sciences.

[9]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[10]  Holger Gerhardt,et al.  Angiogenesis: a team effort coordinated by notch. , 2009, Developmental cell.

[11]  Frederick J. Schoen,et al.  Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering , 2008, Circulation.

[12]  Qiuhui Pan,et al.  Sox9, a key transcription factor of bone morphogenetic protein‐2‐induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter , 2008, Journal of cellular physiology.

[13]  Brendan H. Lee,et al.  Dimorphic effects of Notch signaling in bone homeostasis , 2008, Nature Medicine.

[14]  Tatsuya Kobayashi,et al.  Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation , 2008, Nature Medicine.

[15]  T. Sundt,et al.  Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. , 2007, The Journal of thoracic and cardiovascular surgery.

[16]  R. Bonow,et al.  Calcific aortic stenosis: an update , 2007, Nature Clinical Practice Cardiovascular Medicine.

[17]  R. Kist,et al.  Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. , 2007, Developmental biology.

[18]  C. Steidl,et al.  Combined Loss of Hey1 and HeyL Causes Congenital Heart Defects Because of Impaired Epithelial to Mesenchymal Transition , 2007, Circulation research.

[19]  Shinsuke Yuasa,et al.  Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis , 2006, Nature Medicine.

[20]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[21]  J. Erdmann,et al.  Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. , 2006, Biochemical and biophysical research communications.

[22]  K. Yutzey,et al.  Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. , 2006, Developmental biology.

[23]  R. Hinton,et al.  Extracellular Matrix Remodeling and Organization in Developing and Diseased Aortic Valves , 2006, Circulation research.

[24]  V. Garg,et al.  Molecular genetics of aortic valve disease , 2006, Current opinion in cardiology.

[25]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[26]  R. Norris,et al.  Normal distribution of melanocytes in the mouse heart. , 2005, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[27]  Rosario V. Freeman,et al.  Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.

[28]  W. Edwards,et al.  Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone Formation , 2005, Circulation.

[29]  F. Dagenais,et al.  Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. , 2005, The Journal of heart valve disease.

[30]  Kozo Nakamura,et al.  The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. , 2004, Arthritis and rheumatism.

[31]  Joyce Bischoff,et al.  Heart valve development: endothelial cell signaling and differentiation. , 2004, Circulation research.

[32]  J. Epstein,et al.  Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  David C. Lee,et al.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling , 2003, Journal of Molecular Medicine.

[34]  P. Libby,et al.  Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves , 2001, Circulation.

[35]  D. Srivastava,et al.  Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  V. Lefebvre,et al.  Transcriptional mechanisms of chondrocyte differentiation. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[37]  J. Richardson,et al.  Microsomal triglyceride transfer protein expression during mouse development. , 2000, Journal of lipid research.

[38]  S. Akhtar,et al.  Ultrastructure abnormalities in proteoglycans, collagen fibrils, and elastic fibers in normal and myxomatous mitral valve chordae tendineae. , 1999, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[39]  R. Levy,et al.  Identification and characterization of calcifying valve cells from human and canine aortic valves. , 1999, The Journal of heart valve disease.

[40]  Richard R. Behringer,et al.  Sox9 is required for cartilage formation , 1999, Nature Genetics.

[41]  N. Fujiwara,et al.  Histochemical and immunohistochemical analysis of the mechanism of calcification of Meckel's cartilage during mandible development in rodents , 1999, Journal of anatomy.

[42]  P N Goodfellow,et al.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene , 1997, Molecular and cellular biology.

[43]  M. Thubrikar,et al.  Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. , 1986, The American journal of cardiology.

[44]  Frank McCormick,et al.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.